AWARDDEFINITIVE CONTRACTSmall business
Definitive contract HHSO100200900103CALTIMMUNE, INC.
Overview
Award facts
- Period of performance
- Jun 23, 2016 to Jun 27, 2016
- Ended
- Modifications
- 14
- Latest action Jun 23, 2016
- Contract type
- Definitive contract
- PIID HHSO100200900103C
Description of requirement
DRUGS AND BIOLOGICALS
Dates and value
- Award date
- Signed on Apr 1, 2009
- Potential end of performance
- Jun 26, 2016
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jun 23, 2016. View on USAspending · Recipient on SAM.gov
Recipient
NameALTIMMUNE, INC.
LocationANNAPOLIS, MD
UEIHCX2XDMYTA35
Business sizeSmall businessSize at award, per the contracting officer
Parent companyALTIMMUNE, INC.
Business types and certifications
For-profit organizationCorporation (not tax-exempt)
Self-reported at the time of the action.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- Office Of Assistant Secretary For Preparedness And Response
- BARDA - ASPR / DAAPPO / BARDA DCMA
- Funded by
- Department of Health and Human Services
- Office Of Assistant Secretary For Preparedness And Response
- BARDA - ASPR / DAAPPO / BARDA DCMA
Place of performance
- Place of performance
- United Kingdom
Classification and competition
Classification
- Product or service (PSC)
- 6505DRUGS AND BIOLOGICALS (product)
Competition
- Extent competed
- Full and open competitionA
- Solicitation procedures
- Negotiated proposal/quoteNP
- Set-aside
- No set-aside used
- Contract pricing
- Cost plus fixed feeU
- Offers received
- 4
Contract details
- Subcontracting plan
- Plan not requiredB
- Major program
- Production and testing of anthrax recombinant protective antigen (RPA) vaccine
- Cost Accounting Standards clause
- Not applicable exempt from CASX
- Commercial procedures
- Commercial item procedures not usedD
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not a bundled requirementD
- Consolidated requirement
- No
- Undefinitized action (terms not final)
- No
- Multi-year contract
- Yes
Transaction history
Modification history
- Base award
- Apr 1, 2009Base obligation at award: $32,458,052
- Latest action
- Jun 23, 2016 — CloseoutModification 29; obligation change -$1,514,066; administrative: no change in scope or value
- Latest substantive action
- Sep 10, 2013 — Change orderModification 27; obligation change +$7,984,891
- Actions by type
- Base award1
- Other administrative action7
- Supplemental agreement (within scope)2
- Change order2
- Novation (contract transferred)1
- Closeout1
- Change order definitized1
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- A-76 (FAIR Act) action
- Yes
Pricing and financing
- Paid by purchase card
- No
- Latest action: change in base and exercised options
- -$1,514,066
- Latest action: change in base and all options
- -$1,514,066
Socio-economic and policy
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Mfg outside U.S. - domestic nonavailabilityJ
Structure
- Award or IDV
- Award
- Award type
- Definitive contractD
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7505
- Contracting office code
- 75A501
- Transactions recorded under this award key
- 15
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7505
- Funding office code
- 75A501
- Foreign funding
- Foreign funds non-fmsB